title: Complete response with pegylated liposomal doxorubicin as a second-line therapy in metastatic ovarian carcinosarcoma: Significance of assessment of the response by FDG-PET.
abstract: ► We present a case report of a patient with an ovarian carcinosarcoma who achieve a complete response with PLD as a second-line therapy. ► There is little evidence regarding the effectiveness of second-line therapies in ovarian carcinosarcoma. ► Our case illustrates that the RECIST criteria is unreliable in predicting the histopathological treatment response in carcinosarcomas. ► FDG-PET was significantly more accurate than size-based criteria.
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Gómez-Raposo
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: López-Gómez
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Sereno
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Zambrana
authors.affiliation: Department of Medical Oncology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Casado
keywords: Chemotherapy; FDG-PET; Ovarian carcinosarcoma; Pegylated liposomal doxorubicin